[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100612521":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":10,"centralContacts":19,"locations":25,"responsibleParty":66,"collaborators":10,"id":68,"slug":69,"hasResults":70,"nctId":71,"briefTitle":72,"officialTitle":73,"acronym":74,"eligibilityCriteria":75,"healthyVolunteers":76,"sex":77,"minAge":78,"maxAge":10,"enrollmentInfo":79,"targetDuration":10,"studyType":82,"phases":10,"briefSummary":83,"conditions":84,"keywords":10,"overallStatus":28,"whyStopped":10,"lastUpdateSubmitDate":87,"lastUpdatePostDateStruct":88,"startDateStruct":91,"completionDateStruct":93,"leadSponsor":95,"locationsCount":96},{"fullName":5,"class":6},"Heinrich-Heine University, Duesseldorf","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"neurogenic dysphagia group",null,"patients with neurological diseases that may lead to dysphagia",[13],"Other: medication swallowing",[15],{"type":6,"name":16,"description":17,"armGroupLabels":18,"otherNames":10},"medication swallowing","Three swallow trials will be conducted in randomized order for each of the following conditions:\n\n1. Placebo medication with methylene-blue-dyed water.\n2. Placebo medication with a semi-solid vehicle.\n3. Placebo medication with the swallowing gel GLOUP®.",[9],[20],{"name":21,"role":22,"phone":23,"phoneExt":10,"email":24},"Bendix FEES Labeit, MD","CONTACT","0049211 8117887","Bendix.Labeit@med.uni-duesseldorf.de",[26,42,57],{"facility":27,"status":28,"city":29,"state":30,"zip":31,"country":32,"countryCode":33,"cosmosGeoPoint":34,"geoPoint":39,"contacts":40},"University Hospital Düsseldorf","RECRUITING","Düsseldorf","North Rhine-Westphalia","40225","Germany","DE",{"type":35,"coordinates":36},"Point",[37,38],6.77927,51.22319,{"lat":38,"lon":37},[41],{"name":21,"role":22,"phone":23,"phoneExt":10,"email":24},{"facility":43,"status":28,"city":44,"state":30,"zip":45,"country":32,"countryCode":33,"cosmosGeoPoint":46,"geoPoint":50,"contacts":51},"University Hospital Münster","Münster","48149",{"type":35,"coordinates":47},[48,49],7.62571,51.96236,{"lat":49,"lon":48},[52,56],{"name":53,"role":22,"phone":54,"phoneExt":10,"email":55},"Sonja Suntrup-Krüger, MD","0049251 8355555","Sonja.Suntrup-Krueger@ukmuenster.de",{"name":10,"role":22,"phone":10,"phoneExt":10,"email":55},{"facility":58,"status":28,"city":59,"state":10,"zip":10,"country":32,"countryCode":33,"cosmosGeoPoint":10,"geoPoint":10,"contacts":60},"Hospital Osnabrücl","Onsabrück",[61,65],{"name":62,"role":22,"phone":63,"phoneExt":10,"email":64},"Rainer Dziewas","0049541 4050","Rainer.Dziewas@klinikum-os.de",{"name":10,"role":22,"phone":10,"phoneExt":10,"email":64},{"type":67,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100612521","gel--medication-dysphagia-100612521",false,"NCT07254663","GEL & MEDication Dysphagia","Influence of Swallow Gel and Semi-solid Consistency on Medication Dysphagia: A Multicenter Observational Study","GELMED","Inclusion Criteria:\n\nPatients:\n\nAdults with a dysphagia-associated disease (neurovascular, neurodegenerative, neuroinflammatory, or neuromuscular disorders; in other centers also ENT-related diseases), for whom FEES is clinically indicated.\n\nCapable of providing informed consent and cognitively able to follow the study protocol.\n\nHealthy Controls Adults without any dysphagia-associated disease (no neurovascular, neurodegenerative, neuroinflammatory, or neuromuscular disorders; no ENT-related diseases with structural abnormalities of the oropharynx or esophagus).\n\nCapable of providing informed consent and cognitively able to follow the study protocol.\n\nExclusion Criteria:\n\nNo additional exclusion criteria beyond those specified in the inclusion criteria.",true,"ALL","18 Years",{"count":80,"type":81},500,"ESTIMATED","OBSERVATIONAL","This research project examines the prevalence of medication-related dysphagia in patients with dysphagia-associated diseases. Its primary aim is to assess how frequently swallowing difficulties occur during medication intake and to evaluate the impact of different consistencies-such as semi-solid formulations and commercial swallowing gels-on the swallowing process. Flexible endoscopic evaluation of swallowing serves as the diagnostic gold standard to determine whether alternative administration forms can facilitate safer swallowing. The findings are intended to support the optimization of medication intake and the prevention of complications in patients with dysphagia.",[85,86],"Neurological Diseases or Conditions","Healthy Participants","2025-11-26",{"date":89,"type":90},"2025-11-28","ACTUAL",{"date":92,"type":90},"2025-09-15",{"date":94,"type":81},"2027-09-15",{"name":5,"class":6},3]